Brentuximab vedotin plus chemotherapy for stage III/IV classical Hodgkin lymphoma: 4-year update of the ECHELON-1 study Meeting Abstract


Authors: Radford, J.; Bartlett, N.; Straus, D.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Lech-Maranda, E.; Feldman, T.; Smolewski, P.; Savage, K.; Walewski, J.; Ramchandren, R.; Zinzani, P. L.; Hutchings, M.; Connors, J.; Munoz, J.; Kim, W. S.; Advani, R.; Ansell, S.; Younes, A.; Gallamini, A.; Miao, H.; Liu, R.; Fenton, K.; Forero-Torres, A.; Picardi, M.
Abstract Title: Brentuximab vedotin plus chemotherapy for stage III/IV classical Hodgkin lymphoma: 4-year update of the ECHELON-1 study
Meeting Title: 60th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 189
Issue: Suppl. 1
Meeting Dates: 2020 Apr 27-29
Meeting Location: Birmingham, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-04-01
Start Page: 101
End Page: 102
Language: English
ACCESSION: WOS:000528597400137
PROVIDER: wos
PUBMED: 32337705
DOI: 10.1111/bjh.16638
Notes: Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-PO-089 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. David J Straus
    247 Straus
  2. Anas Younes
    248 Younes